• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

p.A53T PD 患者出现选择性认知障碍和嗅觉减退,而典型 PD 患者则没有。

Selective cognitive impairment and hyposmia in p.A53T PD vs typical PD.

机构信息

From the 2nd Neurology Clinic (C.K., M.S., A.S., I.B., N.P., S.F., D.K., S.G.P., L.S.), Attikon Hospital, National and Kapodistrian University of Athens Medical School, Greece; Neurology Clinic (M.S.), Philipps University, Marburg, Germany; Parkinson's Disease and Movement Disorders Department (M.S.), HYGEIA Hospital; and Neurology Clinic (D.P.), Henry Dunan Hospital, Athens, Greece.

出版信息

Neurology. 2018 Mar 6;90(10):e864-e869. doi: 10.1212/WNL.0000000000005063. Epub 2018 Feb 7.

DOI:10.1212/WNL.0000000000005063
PMID:29438043
Abstract

OBJECTIVE

To evaluate nonmotor symptoms in early /p.A53T Parkinson disease (PD) (A53T PD) compared to typical PD (tPD).

METHODS

The presence of hyposmia, neuropsychiatric, dysautonomic, and sleep disturbances was assessed by standardized questionnaires and validated scales in 18 patients with A53T PD and 18 patients with tPD, matched for age, sex, and disease duration. All patients were enrolled into the Parkinson's Progression Markers Initiative study.

RESULTS

The levodopa equivalent daily dose was higher in the A53T PD ( = 0.018) group vs the tPD group. Scores on the University of Pennsylvania Smell Identification Test ( = 0.001), Benton Judgement of Line Orientation test ( = 0.001), Letter Number Sequencing Test ( = 0.002), and phonemic verbal fluency ( = 0.002) were lower in the A53T PD group vs the tPD group. In contrast, overall cognition, verbal memory, and semantic fluency were similar between groups.

CONCLUSION

The observed selective cognitive impairment reflecting frontal-parietal network dysfunction, together with impaired olfaction, define a set of nonmotor dysfunctions related to A53T PD. These results have implications for the prognosis of patients with A53T PD. Moreover, as the archetypal α-synucleinopathy, such results may give insights into tPD.

摘要

目的

评估早发性 /p.A53T 帕金森病(PD)(A53T PD)与典型 PD(tPD)的非运动症状。

方法

通过标准化问卷和经过验证的量表评估 18 例 A53T PD 患者和 18 例年龄、性别和病程匹配的 tPD 患者的嗅觉减退、神经精神、自主神经和睡眠障碍。所有患者均被纳入帕金森进展标志物倡议研究。

结果

A53T PD 组的左旋多巴等效日剂量较高(=0.018)。宾夕法尼亚大学嗅觉识别测试(=0.001)、本顿判断线定向测试(=0.001)、字母数字序列测试(=0.002)和语音流畅性测试(=0.002)的得分低于 tPD 组。相比之下,两组的总体认知、言语记忆和语义流畅性相似。

结论

观察到的选择性认知障碍反映了额顶叶网络功能障碍,加上嗅觉受损,定义了一组与 A53T PD 相关的非运动功能障碍。这些结果对 A53T PD 患者的预后有影响。此外,作为典型的α-突触核蛋白病,这些结果可能为 tPD 提供一些见解。

相似文献

1
Selective cognitive impairment and hyposmia in p.A53T PD vs typical PD.p.A53T PD 患者出现选择性认知障碍和嗅觉减退,而典型 PD 患者则没有。
Neurology. 2018 Mar 6;90(10):e864-e869. doi: 10.1212/WNL.0000000000005063. Epub 2018 Feb 7.
2
Motor and Nonmotor Features of Carriers of the p.A53T Alpha-Synuclein Mutation: A Longitudinal Study.p.A53Tα-突触核蛋白突变携带者的运动和非运动特征:一项纵向研究。
Mov Disord. 2016 Aug;31(8):1226-30. doi: 10.1002/mds.26615. Epub 2016 Mar 29.
3
APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease.帕金森病中的APOE、MAPT和SNCA基因与认知表现
JAMA Neurol. 2014 Nov;71(11):1405-12. doi: 10.1001/jamaneurol.2014.1455.
4
Initial neuropsychological impairments in patients with the E46K mutation of the α-synuclein gene (PARK 1).携带α-突触核蛋白基因(PARK1)E46K 突变患者的初始神经认知障碍。
J Neurol Sci. 2011 Nov 15;310(1-2):86-9. doi: 10.1016/j.jns.2011.07.047. Epub 2011 Aug 31.
5
Chronic mild stress accelerates the progression of Parkinson's disease in A53T α-synuclein transgenic mice.慢性轻度应激加速A53T α-突触核蛋白转基因小鼠帕金森病的进展。
Exp Neurol. 2016 Nov;285(Pt A):61-71. doi: 10.1016/j.expneurol.2016.09.004. Epub 2016 Sep 13.
6
Hyposmia correlates with SNCA variant and non-motor symptoms in Chinese patients with Parkinson's disease.在中国帕金森病患者中,嗅觉减退与α-突触核蛋白(SNCA)变异及非运动症状相关。
Parkinsonism Relat Disord. 2015 Jun;21(6):610-4. doi: 10.1016/j.parkreldis.2015.03.021. Epub 2015 Mar 31.
7
The heterozygous A53T mutation in the alpha-synuclein gene in a Chinese Han patient with Parkinson disease: case report and literature review.一名中国汉族帕金森病患者α-突触核蛋白基因杂合A53T突变:病例报告及文献复习
J Neurol. 2016 Oct;263(10):1984-92. doi: 10.1007/s00415-016-8213-1. Epub 2016 Jul 8.
8
Odor selectivity of hyposmia and cognitive impairment in patients with Parkinson's disease.帕金森病患者嗅觉减退与认知障碍的气味选择性
Clin Interv Aging. 2017 Oct 9;12:1637-1644. doi: 10.2147/CIA.S147588. eCollection 2017.
9
Serum Uric Acid Level as a Biomarker in Idiopathic and Genetic (p.A53T Alpha-Synuclein Carriers) Parkinson's Disease: Data from the PPMI Study.血清尿酸水平作为特发性和遗传(p.A53T 阿尔法-突触核蛋白携带者)帕金森病的生物标志物:来自 PPMI 研究的数据。
J Parkinsons Dis. 2020;10(2):481-487. doi: 10.3233/JPD-191860.
10
REM sleep behavior disorder and other sleep abnormalities in p. A53T SNCA mutation carriers.携带 A53T SNCA 突变的个体的 REM 睡眠行为障碍和其他睡眠异常。
Sleep. 2021 May 14;44(5). doi: 10.1093/sleep/zsaa248.

引用本文的文献

1
Cognitive Decline in Parkinsonism: From Clinical Phenotypes to the Genetic Background.帕金森病中的认知衰退:从临床表型到遗传背景
Biomedicines. 2025 Jul 2;13(7):1624. doi: 10.3390/biomedicines13071624.
2
Motor and nonmotor features of p.A53T alpha-synuclein PD vs idiopathic PD: longitudinal data from the PPMI study.携带p.A53Tα-突触核蛋白的帕金森病与特发性帕金森病的运动和非运动特征:帕金森病进展标记物计划(PPMI)研究的纵向数据
J Neurol. 2025 Feb 12;272(3):203. doi: 10.1007/s00415-024-12836-w.
3
The novel p.A30G SNCA pathogenic variant in Greek patients with familial and sporadic Parkinson's disease.
希腊家族性和散发性帕金森病患者中的新型p.A30G SNCA致病变体。
Eur J Neurol. 2025 Feb;32(2):e16562. doi: 10.1111/ene.16562.
4
Olfactory dysfunction as potential biomarker in neurodegenerative diseases: a narrative review.嗅觉功能障碍作为神经退行性疾病的潜在生物标志物:一项叙述性综述
Front Neurosci. 2025 Jan 7;18:1505029. doi: 10.3389/fnins.2024.1505029. eCollection 2024.
5
Longitudinal decline in DAT binding in Parkinson's disease: connections with sleep disturbances.帕金森病中多巴胺转运体结合的纵向下降:与睡眠障碍的关联。
BMC Med. 2024 Nov 21;22(1):550. doi: 10.1186/s12916-024-03766-5.
6
Neurofilament light chain as a mediator between LRRK2 mutation and dementia in Parkinson's disease.神经丝轻链作为帕金森病中LRRK2突变与痴呆之间的介导因子。
NPJ Parkinsons Dis. 2023 Sep 12;9(1):132. doi: 10.1038/s41531-023-00572-3.
7
Genetic heterogeneity on sleep disorders in Parkinson's disease: a systematic review and meta-analysis.帕金森病睡眠障碍的遗传异质性:系统评价和荟萃分析。
Transl Neurodegener. 2022 Apr 8;11(1):21. doi: 10.1186/s40035-022-00294-1.
8
Consequences of variability in α-synuclein fibril structure on strain biology.α-突触核蛋白纤维结构变异性对菌株生物学的影响。
Acta Neuropathol. 2022 Mar;143(3):311-330. doi: 10.1007/s00401-022-02403-w. Epub 2022 Feb 4.
9
Brain regions susceptible to alpha-synuclein spreading.易受α-突触核蛋白扩散影响的脑区。
Mol Psychiatry. 2022 Jan;27(1):758-770. doi: 10.1038/s41380-021-01296-7. Epub 2021 Sep 24.
10
Parkinson's Disease Associated with GBA Gene Mutations: Molecular Aspects and Potential Treatment Approaches.与GBA基因突变相关的帕金森病:分子层面及潜在治疗方法
Acta Naturae. 2021 Apr-Jun;13(2):70-78. doi: 10.32607/actanaturae.11031.